Bernardo Lombo, MD
Assistant Professor of Medicine (Cardiovascular Medicine); Affiliated Faculty, Yale Institute for Global Health; Associate Director Echocardiography , Cardiovascular Medicine
Research & Publications
Biography
News
Coauthors
Selected Publications
- Tricuspid and mitral remodelling in atrial fibrillation: a three-dimensional echocardiographic studyOrtiz-Leon XA, Posada-Martinez EL, Trejo-Paredes MC, Ivey-Miranda JB, Pereira J, Crandall I, DaSilva P, Bouman E, Brooks A, Gerardi C, Houle H, Hur DJ, Lin BA, McNamara RL, Lombo-Lievano B, Akar JG, Arias-Godinez JA, Sugeng L. Tricuspid and mitral remodelling in atrial fibrillation: a three-dimensional echocardiographic study. European Heart Journal - Cardiovascular Imaging 2022, 23: 944-955. PMID: 35243501, DOI: 10.1093/ehjci/jeac045.
- Patient Awareness and Clinical Inertia: Obstacles to Hypertension Control in Rural Communities in the Dominican RepublicCastro-Dominguez Y, Paredes M, Mones P, Spatz ES, Lombo B, Sepulveda P, Reyes-Uribe O, Otero J, Ramirez G, Urena P, Lopez E, Dominguez B, McNamara RL. Patient Awareness and Clinical Inertia: Obstacles to Hypertension Control in Rural Communities in the Dominican Republic. American Journal Of Hypertension 2021, 34: 939-947. PMID: 33822861, DOI: 10.1093/ajh/hpab054.
- Understanding Non-P2 Mitral Regurgitation Using Real-Time Three-Dimensional Transesophageal Echocardiography: Characterization and Factors Leading to UnderestimationPosada-Martinez EL, Ortiz-Leon XA, Ivey-Miranda JB, Trejo-Paredes MC, Chen W, McNamara RL, Lin BA, Lombo B, Arias-Godinez JA, Sugeng L. Understanding Non-P2 Mitral Regurgitation Using Real-Time Three-Dimensional Transesophageal Echocardiography: Characterization and Factors Leading to Underestimation. Journal Of The American Society Of Echocardiography 2020, 33: 826-837. PMID: 32387034, DOI: 10.1016/j.echo.2020.03.011.
- Understanding tricuspid valve remodelling in atrial fibrillation using three-dimensional echocardiography.Ortiz-Leon XA, Posada-Martinez EL, Trejo-Paredes MC, Ivey-Miranda JB, Pereira J, Crandall I, DaSilva P, Bouman E, Brooks A, Gerardi C, Ugonabo I, Chen W, Houle H, Akar JG, Lin BA, McNamara RL, Lombo-Lievano B, Arias-Godinez JA, Sugeng L. Understanding tricuspid valve remodelling in atrial fibrillation using three-dimensional echocardiography. European Heart Journal - Cardiovascular Imaging 2020, 21: 747-755. PMID: 32372089, DOI: 10.1093/ehjci/jeaa058.
- Differentiating spontaneous echo contrast, sludge, and thrombus in the left atrial appendage: Can ultrasound enhancing agents help?Posada‐Martinez E, Trejo‐Paredes C, Ortiz‐Leon X, Ivey‐Miranda J, Lin BA, McNamara RL, Arias‐Godinez J, Lombo B, Sugeng L. Differentiating spontaneous echo contrast, sludge, and thrombus in the left atrial appendage: Can ultrasound enhancing agents help? Echocardiography 2019, 36: 1413-1417. PMID: 31260135, DOI: 10.1111/echo.14405.
- Hyperuricemia and Cardiovascular Disease in Patients with Hypertension.Acevedo A, Benavides J, Chowdhury M, Lopez M, Pena L, Montenegro A, Lievano M, Lombo B. Hyperuricemia and Cardiovascular Disease in Patients with Hypertension. Connecticut Medicine 2016, 80: 85-90. PMID: 27024979.
- Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.Lombo B, Alkhalil I, Golden MP, Fotjadhi I, Ravi S, Virata M, Lievano M, Diez J, Ghantous A, Donohue T. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy. Connecticut Medicine 2015, 79: 277-81. PMID: 26245015.
- Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.Lombo B, Díez JG. Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention. Future Cardiology 2011, 7: 281-5. PMID: 21627469, DOI: 10.2217/fca.11.20.
- Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.Lombo B, Díez JG. Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes. Core Evidence 2011, 6: 31-42. PMID: 21468241, PMCID: PMC3065559, DOI: 10.2147/CE.S9510.
- Incidence of coronary stent thrombosis in the «real world»Revista Colombiana de Cardiologia. 2010 Jun; 17(3): 99-105.
- Restrictive Cardiomyopathy as a Presentation of AmyloidosisActa Medica Colombiana, 2010; 35: 126-131
- Prevalence of Metabolic Syndrome in Patients with HIVActa Medica Colombiana. 2008 Dec; 33(4): 282-288
- Prevalence of Metabolic Syndrome in Diabetic PatientsActa Medica Colombiana. 2007 Jan; 32(1): 9-15
- Hepatic Nodular TransformationRevista Colombiana de Gastroenterologia. 2007 Jan; 22(1): 63-67.
- Computed Tomography with Multidetectors in the Diagnosis of Coronary StenosisRevista Colombiana de Cardiologia. 2007 Sep; 14(5): 291-298.
- Primary Vasculitic SyndromesMetodos Diagnosticos en Medicina Interna (pp. 645-653)
- Prevalence of Metabolic Syndrome in the Hypertension Clinic of Fundación Santa Fe de Bogotá University HospitalRevista Colombiana de Cardiologia. 2006 Jun; 12(7): 472-478.
- Pulmonary Epitheloid HaemangioendotheliomaRevista Colombiana de Neumologia. 2006 Sep; 18(3): 114-118